Related Experiment Video

Updated: May 18, 2026

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
08:33

A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers

Published on: January 5, 2024

Pediatric fibromyalgia

D Buskila1, J Ablin

  • 1Soroka Medical Center, Beer-Sheva, Israel. dbuskila@bgumail.bgu.ac.il

Reumatismo
|October 2, 2012
PubMed

Insights

Fibromyalgia (FM) is a chronic pain condition impacting adults and children, characterized by widespread pain and fatigue. Management focuses on education, cognitive changes, and physical exercise, with limited medication use.

Area of Science:

  • Rheumatology
  • Pain Medicine
  • Pediatric Rheumatology

Background:

  • Fibromyalgia (FM) is defined by chronic widespread pain (CWP) and heightened sensitivity to pressure.
  • FM presents with significant fatigue, sleep disturbances, bowel issues, and neuropsychiatric symptoms like anxiety and cognitive dysfunction.
  • The exact cause of FM is unknown but is thought to involve central nervous system (CNS) dysfunction affecting pain processing.

Purpose of the Study:

  • To provide a comprehensive overview of Fibromyalgia Syndrome (FMS), including its definition, associated symptoms, and pathogenesis.
  • To highlight the specific challenges and considerations in diagnosing and managing pediatric FMS.
  • To differentiate pediatric FMS from other inflammatory joint disorders in children.

Main Methods:

  • Literature review and synthesis of current understanding regarding FM definition, symptoms, and pathophysiology.
  • Analysis of diagnostic criteria and differential diagnoses for pediatric FMS.
  • Review of established and emerging management strategies for pediatric FMS.

Main Results:

  • FM is characterized by CWP, allodynia, fatigue, sleep, and cognitive issues, linked to CNS malfunction.
  • Pediatric FMS affects children and adolescents, requiring differentiation from conditions like juvenile idiopathic arthritis (JIA).
  • Management of pediatric FMS prioritizes education, behavioral/cognitive therapy, and physical exercise over pharmacotherapy.

Conclusions:

  • Fibromyalgia is a complex syndrome with diverse symptoms impacting quality of life.
  • Pediatric FMS presents unique challenges in diagnosis and management during critical developmental stages.
  • A multidisciplinary approach emphasizing non-pharmacological interventions is key for managing pediatric FMS effectively.

More Related Videos

Guidelines for Elective Pediatric Fiberoptic Intubation11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...